ProQR (PRQR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jonathan Wolleben from JMP ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $8.08, a high estimate of $13.00, ...
MarketBeat on MSN11mon
2 gene-editing stocks reshaping hereditary disease treatmentsA primary method relies on utilizing clustered, regularly interspaced short palindromic repeats (CRISPR) gene-editing ...
In a paper published in Science Bulletin, a Chinese team of scientists conducted a GFP-activation assay screening 13 Cas12b ...
In this guide, we will explore why nucleic acid quantification is important, the differences between DNA and RNA and the methods used to quantify and assess the purity of DNA and RNA. DNA ...
Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback